Pfizer, which along with Moderna developed successful mRNA vaccines against COVID-19 late last year, announced on Tuesday that it could have ready by the end of the year an experimental oral drug which would treat COVID-19 as soon as patients display symptoms.
Gandhi said that it was a "promising" oral antiviral drug, one that "could be used easily in the outpatient setting to treat COVID-19." Remdesivir is the only other existing antiviral drug used to fight COVID-19; famously, it was administered to President Trump when he contracted the virus.
Because such a drug would be administered to those who contracted COVID-19, and thus were either unvaccinated or breakthrough cases, its utility may be slightly more limited than the vaccine. Dr.